BioAge Labs (BIOA) Other Non-Current Assets (2023 - 2026)
BioAge Labs (BIOA) reported Other Non-Current Assets of $215000.0 for Q1 2026, down 10.04% on a YoY basis from $239000.0 in Q1 2025, and little changed sequentially from $216000.0 in Q4 2025.
BioAge Labs (BIOA) Other Non-Current Assets (2023 - 2026) Analysis & Trends
BioAge Labs (BIOA) has 4 years of Other Non-Current Assets data on file, last reported at $215000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 10.04% year-over-year to $215000.0; the trailing twelve-month figure through Mar 2026 stood at $215000.0 (down 10.04% YoY), and the FY2025 full-year result was $216000.0, down 10.0% from the prior year.
- Other Non-Current Assets was little changed at $215000.0 in Q1 2026, from $216000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $3.3 million in Q4 2023 to a low of $215000.0 in Q1 2026.
- A 4-year average of $667714.3 and a median of $237000.0 in 2025 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets plunged 92.73% in 2024 and retreated 10.0% in 2025, its largest moves.
- Tracing BIOA's Other Non-Current Assets over 4 years: stood at $3.3 million in 2023, then sank by 92.73% to $240000.0 in 2024, then decreased by 10.0% to $216000.0 in 2025, then retreated by 0.46% to $215000.0 in 2026.
- Business Quant data shows BIOA's Other Non-Current Assets at $215000.0 in Q1 2026, $216000.0 in Q4 2025, and $227000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | BioAge Labs | 930.32 Mn | 930.32 Mn | -10.37 Mn | 215,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 215,000.00 |
| Dec 31, 2025 | 216,000.00 |
| Sep 30, 2025 | 227,000.00 |
| Jun 30, 2025 | 237,000.00 |
| Mar 31, 2025 | 239,000.00 |
| Dec 31, 2024 | 240,000.00 |
| Dec 31, 2023 | 3.30 Mn |